Sustained pain‐free at 24 h · migraine headache ‐ moderate or severe pain
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Sustained headache relief at 24 h · migraine headache ‐ moderate or severe pain
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Number of participants reporting an adverse event · migraine headache ‐ moderate or severe pain
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Serious AE · migraine headache ‐ moderate or severe pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Pain end of treatment (0‐10 scale) Higher scores indicate higher pain levels · Patients with fibromyalgia
1 finding from 1 review
Health‐related quality of life end of treatment (0‐80 scale) Higher scores indicate lower health‐related quality of life · patients with fibromyalgia
1 finding from 1 review
Fatigue · patients with fibromyalgia
2 findings from 1 review
Participant‐reported sleep problems (scale: 0 to 28; higher scores indicate more sleep problems) · patients with fibromyalgia
2 findings from 1 review
Health‐related quality of life · patients with fibromyalgia
1 finding from 1 review
Acceptability · patients with fibromyalgia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Pain · Patients with fibromyalgia
1 finding from 1 review
Intervention not reported
Negative mood end of treatment (0‐10 scale) Higher scores indicate higher negative mood levels · Patients with fibromyalgia
1 finding from 1 review
Intervention not reported
Negative mood · Patients with fibromyalgia
1 finding from 1 review
Intervention not reported
Disability end of treatment (0‐10 scale) Higher scores indicate disability levels · Patients with fibromyalgia
1 finding from 1 review
Intervention not reported
Disability · Patients with fibromyalgia
1 finding from 1 review
Intervention not reported
Acceptability end of treatment (dropouts from study due to any reasons) · Patients with fibromyalgia
The intervention showed no clear difference in acceptability end of treatment (dropouts from study due to any… (low certainty).
1 finding from 1 review
At least 50% reduction in pain · patients with fibromyalgia
Pregabalin leads to higher 50% pain reduction compared with placebo at end of treatment (high certainty).
1 finding from 1 review
Patient Global Impression of Change much or very much improved · patients with fibromyalgia
Pregabalin leads to higher patient Global Impression of Change of 'much' or 'very much' improved compared with placebo at end of treatment (high certainty).
1 finding from 1 review
Fatigue · patients with fibromyalgia
1 finding from 1 review
Participant‐reported sleep problems (scale: 0 to 28; higher scores indicate more sleep problems) · patients with fibromyalgia
1 finding from 1 review